Safety concerns about new drugs revealed
- Details
- Category: Research
What's safer: a newly approved drug or one that has been on the market much longer? Newer drugs have a one in three chance of acquiring a black box warning or being withdrawn for safety reasons within 25 years of their approval, according to a new study by researchers from Cambridge Health Alliance /Harvard Medical School, Boston Medical Center (BMC)/Boston University School of Medicine (BUSM), City University of New York School of Public Health, and Public Citizen.
Pepper and halt: Spicy chemical may inhibit gut tumors
- Details
- Category: Research
Researchers at the University of California, San Diego School of Medicine report that dietary capsaicin - the active ingredient in chili peppers - produces chronic activation of a receptor on cells lining the intestines of mice, triggering a reaction that ultimately reduces the risk of colorectal tumors. The findings are published in the August 1, 2014 issue of The Journal of Clinical Investigation.
Recent use of some birth control pills may increase breast cancer risk
- Details
- Category: Research
Women who recently used birth control pills containing high-dose estrogen and a few other formulations had an increased risk for breast cancer, whereas women using some other formulations did not, according to data published in Cancer Research, a journal of the American Association for Cancer Research.
Five daily portions of fruit and vegetables may be enough to lower risk of death
- Details
- Category: Research
These results conflict with a recent study published in BMJ's Journal of Epidemiology and Community Health suggesting that seven or more daily portions of fruits and vegetables were linked to lowest risk of death. There is growing evidence that increasing fruit and vegetable consumption is related to a lower risk of death from cardiovascular disease and cancer.
Scientists discover new, noncommittal mechanism of drug resistance
- Details
- Category: Research
Microorganisms like bacteria and fungi can evade treatment by acquiring mutations in the genes targeted by antibiotics or antifungal drugs. These permanent mutations were once thought to be the only way for drug-resistant strains to evolve. Now a new study has shown that microorganisms can use a temporary silencing of drug targets - known as epimutations - to gain the benefits of drug resistance without the commitment.
Drugs used to treat lung disease work with the body clock
- Details
- Category: Research
Scientists from The University of Manchester have discovered why medication to treat asthma and pneumonia can become ineffective. The findings, published in Nature Medicine, show that drugs widely used to treat lung diseases work with the body clock. In the UK pneumonia, which is caused by an infection, affects around 1 in 1000 adults each year and is more serious for babies, young children, the elderly, smokers and those with an underlying health condition.
Paracetamol no better than placebo for lower back pain
- Details
- Category: Research
Paracetamol is no better than placebo at speeding recovery from acute episodes of lower back pain or improving pain levels, function, sleep, or quality of life, according to the first large randomised trial to compare the effectiveness of paracetamol with placebo for low-back pain. The findings, published in The Lancet, question the universal endorsement of paracetamol as the first choice painkiller for low-back pain, say the authors.
More Pharma News ...
- Rosemary and oregano contain diabetes-fighting compounds
- Transparency lacking in clinical trials
- Researchers eliminate the HIV virus from cultured human cells for first time
- Niacin too dangerous for routine cholesterol therapy
- Taking B vitamins won't prevent Alzheimer's disease
- Scientists find genetic recipe to turn stem cells to blood
- Patient-specific stem cells and personalized gene therapy